After Hours Summary: SWHC +4.6% following upside guidanceAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: SWHC +4.6%
Companies trading higher in after hours in reaction to news: EXEL +6.7% (announced 'positive' results from subgroup analyses of the meteor Phase 3 pivotal trial; Data further underscore clinical benefit of cabozantinib across subgroups of patients with advanced renal cell carcinoma), BIN +6% (following Bloomberg report suggesting possible sale), RPRX +3.9% (expects to meet with FDA to discuss 'Complete Response Letter' for enclomiphene NDA during February 2016; Marketing Authorization Application for enclomiphene planned for submission in Europe mid-2016), HIW +3.4% (has agreed to sell Country Club Plaza portfolio in Kansas City for $660 mln to a Taubman Centers (TCO) and The Macerich Company (MAC) joint venture), VCEL +2.7% (submits Biologics License Application to the FDA for MACI for the treatment of cartilage defects in the knee)
After Hours Losers:
Companies trading lower in after hours in reaction to news: AKBA -4.5% (initiated Phase 3 Pro2tect program, announced proposed $75 mln public offering as part of previously disclosed shelf offering), XLRN -2.3% (filed $300 mln common stock offering; announced proposed $150 mln offering of common stock)